Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Update

Viemed Healthcare, Inc. (NASDAQ:VMD) saw a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 361,200 shares, a growth of 18.4% from the October 15th total of 305,100 shares. Approximately 1.1% of the company’s shares are short sold. Based on an average daily volume of 155,500 shares, the short-interest ratio is presently 2.3 days.

Insiders Place Their Bets

In other news, Director Nitin Kaushal sold 30,000 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $9.56, for a total transaction of $286,800.00. Following the sale, the director now owns 126,843 shares of the company’s stock, valued at approximately $1,212,619.08. This represents a 19.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the completion of the sale, the director now owns 107,706 shares in the company, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 20.00% of the company’s stock.

Institutional Trading of Viemed Healthcare

A number of institutional investors have recently bought and sold shares of the business. National Bank of Canada FI lifted its position in Viemed Healthcare by 91.2% in the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after acquiring an additional 1,596 shares during the last quarter. Oppenheimer Asset Management Inc. increased its position in shares of Viemed Healthcare by 5.6% during the third quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock worth $222,000 after purchasing an additional 1,601 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Viemed Healthcare by 14.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,918 shares of the company’s stock valued at $98,000 after purchasing an additional 1,912 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Viemed Healthcare by 21.1% in the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock valued at $84,000 after purchasing an additional 2,226 shares during the period. Finally, Panagora Asset Management Inc. increased its position in Viemed Healthcare by 1.1% during the second quarter. Panagora Asset Management Inc. now owns 272,383 shares of the company’s stock worth $1,784,000 after buying an additional 2,904 shares during the period. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Stock Down 2.3 %

VMD stock opened at $8.85 on Friday. Viemed Healthcare has a fifty-two week low of $6.21 and a fifty-two week high of $10.44. The company’s 50 day moving average price is $8.37 and its 200 day moving average price is $7.54. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm has a market capitalization of $344.59 million, a price-to-earnings ratio of 32.78 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. The business had revenue of $58.00 million for the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.